1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone

We are 1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone CAS:221615-75-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone
CAS.NO: 221615-75-4
Synonyms:
1-(6-methylpyridin-3-yl)-2-[(4-methylsulfonyl)-phenyl]-ethanone
2-(4-methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-ethanone
2-(4-MESYLPHENYL)-1-(6-METHYLPYRIDIN-3-YL)-ETHAN-1-ONE
1-(6-methylpyridin-3-yl)-2-[4-(methylsulphonyl)phenyl]ethanone
Ethanone, 1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]-
1-(6-methyl-3-pyridinyl)-2[4-(methylthio)phenyl]ethanone
1-(6-Methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone
1-(6-Methyl-3-pyridyl)-2-(4-methylsulfonylphenyl)ethanone

Molecular Formula: C15H15NO3S
Molecular Weight:   289.349

Physical and Chemical Properties:
Density: 1.2±0.1 g/cm3
Boiling point: 509.7±50.0 °C at 760 mmHg
Melting point: /
Flash point: 262.1±30.1 °C
Refractive index: 1.573

Specification:
Appearance: White crystalline powder odorless, bitter taste
Purity:≥99.0%
Heavy metal:≤10ppm
Residue on ignition:≤0.2%
Single impurity:≤0.2%
Total impurity:≤1.0%
Loss on drying :≤0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Etoricoxib CAS:202409-33-4.

Related News: Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.3-Amino-4-pyrazolecarbonitrile The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.2,3-dimethylbenzoic acid The company’s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.7-Bromo-1-heptanol Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine.